Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.

Canadian journal of anaesthesia = Journal canadien d'anesthesie - 1 Nov 1995

Miller D R, Bryson G, Martineau R J, Kitts J B, Curran M, Bragg P, Watson J B, Hull K, Lindsay P

Abstract excerpt

Mivacurium is a new non-depolarizing muscle relaxant consisting of three stereoisomers. The two active isomers (cis-trans and trans-trans) undergo rapid metabolism by plasma cholinesterase (t1/2 beta < 2 min). Due to its rapid elimination, the need for reversal of mivacurium-induced neuromuscular block is controversial, and to date there have been no studies evaluating reversal of deep blocks. The object of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cholinesterase Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholinesterases

Share to Double-Blind Method

Share to Genotype

Share to Isoquinolines

Source

Identifiers

PMID: 8590511
DOI: 10.1007/BF03011072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.PMID 8590511Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).Semantic proximity Read ↗

Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.Semantic proximity Read ↗

Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.Semantic proximity Read ↗

Severe allergic reactions induced by different muscle relaxants in the same patient in two rounds of general anaesthesia: A case report and a literature reviewSemantic proximity Read ↗

Clinical importance of plasma cholinesterase for the anaesthetist.Semantic proximity Read ↗

Prolonged neuromuscular block associated with mivacurium.Semantic proximity Read ↗

Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients.Semantic proximity Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.Semantic proximity Read ↗

The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase.Semantic proximity Read ↗

Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.Semantic proximity Read ↗

Prolonged mivacurium neuromuscular block in children.Semantic proximity Read ↗

Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.